Nasal immunization of mice with Lactobacillus casei expressing the pneumococcal surface protein C primes the immune system and decreases pneumococcal nasopharyngeal colonization in mice

FEMS Immunology and Medical Microbiology

Volumn 62, Issue 3, 2011, Pages 263-272

  de Lúcia Hernani, Marília ^a   Ferreira, Patrícia Cristina Duarte ^a   Ferreira, Daniela Mulari ^a   Miyaji, Eliane Namie ^a   Ho, Paulo Lee ^a   Oliveira, Maria Leonor Sarno ^a  

^a INSTITUTO BUTANTAN   (Brazil)

Author keywords

Lactobacillus casei; Pneumococcal colonization; PspC

Indexed keywords

IMMUNOGLOBULIN A; PNEUMOCOCCAL SURFACE PROTEIN C; PNEUMOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL COLONIZATION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; IMMUNIZATION; IMMUNOGLOBULIN PRODUCTION; INFECTION PREVENTION; LACTOBACILLUS CASEI; MOUSE; NASOPHARYNX; NONHUMAN; NUCLEOTIDE SEQUENCE; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; CYTOKINES; FEMALE; IMMUNIZATION; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LACTOBACILLUS CASEI; MICE; MICE, INBRED C57BL; NASOPHARYNX; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; RECOMBINANT PROTEINS; STATISTICS, NONPARAMETRIC; STREPTOCOCCUS PNEUMONIAE;

EID: 79960359307     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2011.00809.x     Document Type: Article

References (43)

1. Aida Y & Pabst MJ (1990) Removal of endotoxin from protein solutions by phase separation using Triton X-114. J Immunol Methods 132: 191-195.
2. Balachandran P, Brooks-Walter A, Virolainen-Julkunen A, Hollingshead SK & Briles DE (2002) Role of pneumococcal surface protein C in nasopharyngeal carriage and pneumonia and its ability to elicit protection against carriage of Streptococcus pneumoniae. Infect Immun 70: 2526-2534.
3. Basset A, Thompson CM, Hollingshead SK, Briles DE, Ades EW, Lipsitch M & Malley R (2007) Antibody-independent, CD4+ T-cell-dependent protection against pneumococcal colonization elicited by intranasal immunization with purified pneumococcal proteins. Infect Immun 75: 5460-5464.
4. Bettinger JA, Scheifele DW, Kellner JD, Halperin SA, Vaudry W, Law B & Tyrrell G (2010) The effect of routine vaccination on invasive pneumococcal infections in Canadian children, Immunization Monitoring Program, Active 2000-2007. Vaccine 28: 2130-2136.
5. Brooks-Walter A, Briles DE & Hollingshead SK (1999) The pspC gene of Streptococcus pneumoniae encodes a polymorphic protein, PspC, which elicits cross-reactive antibodies to PspA and provides immunity to pneumococcal bacteremia. Infect Immun 67: 6533-6542.
6. Campos IB, Darrieux M, Ferreira DM et al. (2008) Nasal immunization of mice with Lactobacillus casei expressing the Pneumococcal Surface Protein A: induction of antibodies, complement deposition and partial protection against Streptococcus pneumoniae challenge. Microbes Infect 10: 481-488.
7. Cangemi de Gutierrez R, Santos V & Nader-Macias ME (2001) Protective effect of intranasally inoculated Lactobacillus fermentum against Streptococcus pneumoniae challenge on the mouse respiratory tract. FEMS Immunol Med Mic 31: 187-195.
8. Cao J, Chen D, Xu W et al. (2007) Enhanced protection against pneumococcal infection elicited by immunization with the combination of PspA, PspC, and ClpP. Vaccine 25: 4996-5005.
9. Cross ML (2002) Microbes versus microbes: immune signals generated by probiotic lactobacilli and their role in protection against microbial pathogens. FEMS Immunol Med Mic 34: 245-253.
10. Dagan R (2009) New insights on pneumococcal disease: what we have learned over the past decade. Vaccine 27 (suppl 3): C3-C5.
11. Dave S, Brooks-Walter A, Pangburn MK & McDaniel LS (2001) PspC, a pneumococcal surface protein, binds human factor H. Infect Immun 69: 3435-3437.
12. Dave S, Carmicle S, Hammerschmidt S, Pangburn MK & McDaniel LS (2004) Dual roles of PspC, a surface protein of Streptococcus pneumoniae, in binding human secretory IgA and factor H. J Immunol 173: 471-477.
13. de Quadros CA (2009) From global to regional: the importance of pneumococcal disease in Latin America. Vaccine 27 (suppl 3): C29-C32.
14. Ferreira DM, Darrieux M, Oliveira ML, Leite LC & Miyaji EN (2008) Optimized immune response elicited by a DNA vaccine expressing pneumococcal surface protein a is characterized by a balanced immunoglobulin G1 (IgG1)/IgG2a ratio and proinflammatory cytokine production. Clin Vaccine Immunol 15: 499-505.
15. Ferreira DM, Darrieux M, Silva DA et al. (2009) Characterization of protective mucosal and systemic immune responses elicited by pneumococcal surface protein PspA and PspC nasal vaccines against a respiratory pneumococcal challenge in mice. Clin Vaccine Immunol 16: 636-645.
16. Ferreira DM, Oliveira ML, Moreno AT, Ho PL, Briles DE & Miyaji EN (2010) Protection against nasal colonization with Streptococcus pneumoniae by parenteral immunization with a DNA vaccine encoding PspA (Pneumococcal surface protein A). Microb Pathogenesis 48: 205-213.
17. Ferreira PC, Campos IB, Abe CM, Trabulsi LR, Elias WP, Ho PL & Oliveira ML (2008) Immunization of mice with Lactobacillus casei expressing intimin fragments produces antibodies able to inhibit the adhesion of enteropathogenic Escherichia coli to cultivated epithelial cells. FEMS Immunol Med Mic 54: 245-254.
18. Fukuyama Y, King JD, Kataoka K et al. (2010) Secretory-IgA antibodies play an important role in the immunity to Streptococcus pneumoniae. J Immunol 185: 1755-1762.
19. Hammerschmidt S, Agarwal V, Kunert A, Haelbich S, Skerka C & Zipfel PF (2007) The host immune regulator factor H interacts via two contact sites with the PspC protein of Streptococcus pneumoniae and mediates adhesion to host epithelial cells. J Immunol 178: 5848-5858.
20. Hsu KK, Shea KM, Stevenson AE & Pelton SI (2010) Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001-2007. Pediatr Infect Dis J 29: 289-293.
21. Iannelli F, Oggioni MR & Pozzi G (2002) Allelic variation in the highly polymorphic locus pspC of Streptococcus pneumoniae. Gene 284: 63-71.
22. Li J, Glover DT, Szalai AJ, Hollingshead SK & Briles DE (2007) PspA and PspC minimize immune adherence and transfer of pneumococci from erythrocytes to macrophages through their effects on complement activation. Infect Immun 75: 5877-5885.
23. Lu YJ, Gross J, Bogaert D et al. (2008) Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog 4: e1000159.
24. Malley R, Srivastava A, Lipsitch M, Thompson CM, Watkins C, Tzianabos A & Anderson PW (2006) Antibody-independent, interleukin-17A-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide. Infect Immun 74: 2187-2195.
25. Mohamadzadeh M, Olson S, Kalina WV et al. (2005) Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. P Natl Acad Sci USA 102: 2880-2885.
26. Mohamadzadeh M, Duong T, Sandwick SJ, Hoover T & Klaenhammer TR (2009) Dendritic cell targeting of Bacillus anthracis protective antigen expressed by Lactobacillus acidophilus protects mice from lethal challenge. P Natl Acad Sci USA 106: 4331-4336.
27. O'Brien KL, Wolfson LJ, Watt JP et al. (2009) Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 374: 893-902.
28. Ogunniyi AD, Woodrow MC, Poolman JT & Paton JC (2001) Protection against Streptococcus pneumoniae elicited by immunization with pneumolysin and CbpA. Infect Immun 69: 5997-6003.
29. Ogunniyi AD, Grabowicz M, Briles DE, Cook J & Paton JC (2007) Development of a vaccine against invasive pneumococcal disease based on combinations of virulence proteins of Streptococcus pneumoniae. Infect Immun 75: 350-357.
30. Oliveira ML, Areas AP, Campos IB et al. (2006) Induction of systemic and mucosal immune response and decrease in Streptococcus pneumoniae colonization by nasal inoculation of mice with recombinant lactic acid bacteria expressing pneumococcal surface antigen A. Microbes Infect 8: 1016-1024.
31. Palaniappan R, Singh S, Singh UP et al. (2005) Differential PsaA-, PspA-, PspC-, and PdB-specific immune responses in a mouse model of pneumococcal carriage. Infect Immun 73: 1006-1013.
32. Pilishvili T, Lexau C, Farley MM et al. (2010) Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 201: 32-41.
33. Plant LJ & Conway PL (2002) Adjuvant properties and colonization potential of adhering and non-adhering Lactobacillus spp. following oral administration to mice. FEMS Immunol Med Mic 34: 105-111.
34. Quin LR, Onwubiko C, Moore QC, Mills MF, McDaniel LS & Carmicle S (2007) Factor H binding to PspC of Streptococcus pneumoniae increases adherence to human cell lines in vitro and enhances invasion of mouse lungs in vivo. Infect Immun 75: 4082-4087.
35. Racedo S, Villena J, Medina M, Aguero G, Rodriguez V & Alvarez S (2006) Lactobacillus casei administration reduces lung injuries in a Streptococcus pneumoniae infection in mice. Microbes Infect 8: 2359-2366.
36. Steidler L, Wells JM, Raeymaekers A, Vandekerckhove J, Fiers W & Remaut E (1995) Secretion of biologically active murine interleukin-2 by Lactococcus lactis subsp. lactis. Appl Environ Microb 61: 1627-1629.
37. Techasaensiri C, Messina AF, Katz K, Ahmad N, Huang R & McCracken GH Jr (2010) Epidemiology and evolution of invasive pneumococcal disease caused by multidrug resistant serotypes of 19A in the 8 years after implementation of pneumococcal conjugate vaccine immunization in Dallas, Texas. Pediatr Infect Dis J 29: 294-300.
38. Trzcinski K, Thompson C, Malley R & Lipsitch M (2005) Antibodies to conserved pneumococcal antigens correlate with, but are not required for, protection against pneumococcal colonization induced by prior exposure in a mouse model. Infect Immun 73: 7043-7046.
39. Villena J, Racedo S, Aguero G, Bru E, Medina M & Alvarez S (2005) Lactobacillus casei improves resistance to pneumococcal respiratory infection in malnourished mice. J Nutr 135: 1462-1469.
40. Weiser JN (2010) The pneumococcus: why a commensal misbehaves. J Mol Med 88: 97-102.
41. Wells JM & Mercenier A (2008) Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria. Nat Rev Microbiol 6: 349-362.
42. Zhang JR, Mostov KE, Lamm ME, Nanno M, Shimida S, Ohwaki M & Tuomanen E (2000) The polymeric immunoglobulin receptor translocates pneumococci across human nasopharyngeal epithelial cells. Cell 102: 827-837.
43. Zhang Z, Clarke TB & Weiser JN (2009) Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. J Clin Invest 119: 1899-1909.